Clinical Trial Update: Rasburicase in Tumor Lysis Syndrome [Phase 4]

View source ↗

Summary

Phase 4 trial update indicating completion of rasburicase studies for tumor lysis syndrome with associated hyperuricemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperuricemia
• Tumor Lysis Syndrome

Drugs mentioned

• Rasburicase (rasburicase)

Snippet

Sponsor: Sanofi | Conditions: Hyperuricemia | Phase 4 | Status: COMPLETED